Advanced oxidation treatment of drinking water: Part I. occurrence and removal of pharmaceuticals and endocrine-disrupting compounds from Lake Huron water

Ozone: Science and Engineering

Volumn 32, Issue 4, 2010, Pages 217-229

  Rahman, Mohammad Feisal ^a   Yanful, Earnest K ^a   Jasim, Saad Y ^a,b   Bragg, Leslie M ^c   Servos, Mark R ^c   Ndiongue, Souleymane ^b   Borikar, Devendra ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Walkerton Clean Water Centre   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Advanced Oxidation Process; Drinking Water; Endocrine Disrupting Compounds; Lake Huron; Ozone; Pharmaceuticals

Indexed keywords

ADVANCED OXIDATION PROCESS; ADVANCED OXIDATION PROCESSES; ADVANCED OXIDATION TREATMENT; CONVENTIONAL TREATMENTS; DRINKING WATER; ENDOCRINE DISRUPTING COMPOUND; ENDOCRINE-DISRUPTING COMPOUNDS; METHOD DETECTION LIMITS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PILOT SCALE; PRE-COAGULATION; TARGET COMPOUND; TARGET POLLUTANTS; TREATMENT PLANTS;

AIR POLLUTION; COAGULATION; DEWATERING; LAKES; OXIDATION; OXIDATION RESISTANCE; OZONE; POLLUTION DETECTION; POTABLE WATER; REMOVAL; TARGETS; WATER POLLUTION; WATER RECYCLING;

CHEMICAL WATER TREATMENT;

EID: 77955115781     PISSN: 01919512     EISSN: 15476545     Source Type: Journal    
DOI: 10.1080/01919512.2010.489185     Document Type: Article

References (62)

1. th National Conference on Drinking Water, Charlottetown, Prince Edward Island, Canada, August 11-13, 1996.
2. Acero, J.L and U. Von Gunten, "Characterization of Oxidation Processes: Ozonation and the AOP O3/H2O2", JAWWA, 93(10): 90-100 (2001).
3. Barnes, K.K., D.W. Kolpin, E.T. Furlong, S.D. Zaugg, M.T. Meyer and L.B. Barber, "A National Reconnaissance of Pharmaceuticals and Other Organic Wastewater Contaminants in the United States- I) Groundwater", Sci. Total Environ., 402:192-200 (2008).
4. Benotti, M.J., R.A. Trenholm, B.J. Vanderford, J.C. Holady, B.D. Stanford, and S.A. Snyder, "Pharmaceuticals and Endocrine Disrupting Compounds in U.S. Drinking Water", Environ. Sci. Technol., 43: 597-603 (2009).
5. Boyd, G.R., H. Reemtsma, D.A. Grimm, and S. Mitra, "Pharmaceuticals and Personal Care Products in Surface and Treated Water of Louisiana, USA and Ontario, Canada", Sci. Total Environ., 311:135-149 (2003).
6. Chang, S. and P. Singer, "The Impact of Ozonation on Particle Stability and the Removal of TOC and THM Precursors", JAWWA 83(3): 71-79 (1991).
7. Colon, I., D. Caro, C.J. Bourdony, and O. Rosario, "Identification of Phthalate Esters in the Serum of Young Puerto Rican Girls with Premature Breast Development", Environ. Health Perspect., 108(9): 895-900 (2000).
8. Farvardin, M. and A. Collins, "Preozonation as an Aid in the Coagulation of Humic Substances-Optimum Preozonation Dose", Water Res., 23(3): 307-316 (1989).
9. Guillette Jr., L.J., T.S. Gross, G.R. Masson, J.M. Matter, H.F. Percival, and A.R. Woodward, "Developmental Abnormalities of the Gonad and Abnormal Sex Hormone Concentrations in Juvenile Alligators from Contaminated and Control Lakes in Florida", Environ. Health Perspect., 102(8):680-688 (1994).
10. Halling-Sorensen, B., S.N. Nielsen, P.F. Lanzky, F. Ingerslev, H.C. Holten Lutzhot, and S.E. Jorgensen, "Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment-A Review", Chemosphere, 36(2):357-393 (1998).
11. Hemminki, E., M. Gissler, and J. Merilainen, "Reproductive Effects of in Utero Exposure to Estrogen and Progestin Drugs", Fertil. Steril., 71:1092-1098 (1998).
12. Hua, W.Y., E.R. Bennet, X-S. Maio, C.D. Metcalfe, and R.J. Letcher, "Seasonality Effects on Pharmaceuticals and S-Triazine Herbicides in Wastewater Effluent and Surface Water from the Canadian Side of the Upper Detroit River", Environ. Toxicol. Chem., 25(9):2356-2365 (2006a).
13. Hua, W., E.R. Bennet, and R.J. Letcher, "Ozone Treatment and the Depletion of Detectable Pharmaceuticals and Atrazine Herbicide in Drinking Water Sourced From Upper Detroit River, Ontario, Canada", Water Res., 40: 2259-2266 (2006b).
14. Huber, M.M., A. Gobel, A. Joss, N. Hermann, D. Loffler, C.S. Mcardell, A. Ried, H. Siegritst, T.A. Ternes, and U. Von Gunten, "Oxidation of Pharmaceuticals During Ozonation of Municipal Wastewater Effluents: A Pilot Study", Environ. Sci. Technol., 39:4290-4299 (2005).
15. Huber, M.M., S. Canonica, G.-Y. Park, and U. Von Gunten, "Oxidation of Pharmaceuticals During Ozonation and Advanced Oxidation Processes", Environ. Sci. Technol., 37:1016-1024 (2003).
16. Irabelli, A., S.Y. Jasim, and N. Biswas, "Pilot Scale Evaluation of Ozone vs Peroxone for Trihalomethane Formation", Ozone Sci. Eng. 30(5):356-366 (2008).
17. Jasim, S.Y., S. Ndiongue, B. Johnson, L. Schweitzer, and D. Borikar, "The Effect of Ozone on Cold Water Coagulation", Ozone Sci. Eng., 30(1):27-33 (2008).
18. Jasim, S.Y., A. Irabelli, P. Yang, S. Ahmed, and L. Schweitzer, "Presence of Pharmaceuticals and Pesticides in Detroit River Water and the Effect of Ozone on Removal", Ozone Sci. Eng., 28:415-423 (2006).
19. Jones, O.A.H., J.N. Lester, and N. Voulvoulis, "Pharmaceuticals: A Threat to Drinking Water?", Trends Biotechnol., 23(4):163-167 (2005).
20. Kavanagh, R.J., G.C. Balch, Y. Kiparissis, A.J. Niimi, J. Sherry, C. Tinson, and C.D. Metcalfe, "Endocrine Disruption and Altered Gonadal Development in White Perch (Morone americana) from the Lower Great Lakes Region", Environ. Health Perspect., 112(8): 898-902 (2004).
21. Kim, S.D., J. Cho, I.S. Kim, B. J. Vanderford, and S.A. Snyder, "Occurrence and Removal of Pharmaceuticals and Endocrine Disruptors in South Korean Surface, Drinking and Waste Waters", Water Res., 411:1013-1021 (2007).
22. Kolpin, D.W., E.T. Furlong, M.T. Meyer, E.M. Thurman, S.D. Zaugg, L.B. Barber, and H.T. Buxton, "Pharmaceuticals, Hormones and Other Organic Wastewater Contaminants in US Streams, 1999-2000: A National Reconnaissance", Environ. Sci. Technol., 36:1202-1211 (2002).
23. Lintelmann, J., A. Katayama, N. Kurihara, L. Shore, A. Wenzel, "Endocrine Disruptors in the Environment", Pure Appl. Chem., 75(5):631-681 (2003).
24. Marcus, M., J. Kiely, F. Xu, M. McGeehin, R. Jackson, T. and Sinks, "Changing Sex Ratio in the United States, 1969-1995", Fertil. Steril., 70:270-273 (1998).
25. Mazloum, S., S. Jasim, N. Biswas, K. Rakness, and G. Hunter, "Improvement and Optimization of the A.H. Weeks Water Treatment Plant Processes", Ozone Sci. Eng., 26(2):125-140 (2004).
26. Mcdowell, D.C., M. Huber, M. Wagner, U. Von Gunten, and T.A. Ternes, "Ozonation of Carbamazepine in Drinking Water: Identification and Kinetic Study of Major Oxidation Products", Environ. Sci. Technol., 39:8014-8022 (2005).
27. Metcalfe, C.D., B.G. Koenig, D.T. Bennie, M. Servos, T.A. Ternes, and R. Hirsch, "Occurrence of Neutral and Acidic Drugs in the Effluents of Canadian Sewage Treatment Plants", Environ. Toxicol. Chem., 22(12): 2872-2880 (2003a).
28. Metcalfe, C.D., X.-S. Miao, B.G. Koenig, and J. Struger, "Distribution of Acidic and Neutral Drugs in Surface Waters Near Sewage Treatment Plants in the Lower Great Lakes, Canada", Environ. Toxicol. Chem., 22(12):2881-2889 (2003b).
29. Metcalfe, C., X.-S. Miao, W. Hua, R. Letcher, and M. Servos, "Pharmaceuticals in the Canadian Environment", Pharmaceuticals in the Environment-Sources, Fate, Effects and Risks (Heidelberg, Germany: Springer, 2004).
30. Orlando, E.F. and L.J. Guillette, "Sexual Dimorphic Responses in Wildlife Exposed to Endocrine Disrupting Chemicals", Environ. Res., 104(1):163-173 (2007).
31. Paode, R., M. Chandrakanth, G. Amy, J. Gramith, and D. Ferguson, "Ozone Versus Ozone/Peroxide Induced Particle Destabilization and Aggregation: A Pilot Study", Ozone Sci. Eng., 17:25-51 (1995).
32. Peng, X., Y. Yu, C. Tang, J. Tan, Q. Huang, and Z. Wang, "Occurrence of Steroid Estrogens, Endocrine-disrupting Phenols and Acid Pharmaceuticals Residues in Urban Riverine Water of the Pearl River Delta, South China", Sci. Total Environ., 397:158-166 (2008).
33. Petrovic M, S. Gonzalez, and D. Barcelo, "Analysis and Removal of Emerging Contaminants in Wastewater and Drinking Water", Trends Anal. Chem., 22 (10):685-696 (2003).
34. Pocar, P., T.A.L. Bervini, B. Fischer, and F. Gandolfi, "The Impact of Endocrine Disruptors on Oocyte Competence", Reproduction, 125:313-325 (2003).
35. Proffitt, F. and P. Bagla, "Circling in on a Vulture Killer", Science, 306:223 (2004).
36. Purdom, C.E., P.A. Hardiman, V.J. Bye, N.C. Eno, C.R. Tyler, and J.P. Sumpter, "Estrogenic Effects of Effluents from Sewage Treatment Works", Chem. Ecol., 8:275-285 (1994).
37. Rahman, M.F., Removal of Endocrine Disrupting Compounds and Pharmaceuticals and Personal Care Products from Drinking Water, Thesis Submitted to the Department of Civil and Environmental Engineering, University of Western Ontario (2008), P.160.
38. Rahman, M.F, E.K. Yanful, and S.Y. Jasim, "Endocrine Disrupting Compounds (EDCs) and Pharmaceuticals and Personal Care Products (PPCPs) in the Aquatic Environment: Implications for the Drinking Water Industry and Global Environmental Health", J. Water Health, 7(2):224-243 (2009).
39. Rakness, K.L., Ozone in Drinking Water Treatment: Process Design, Operation and Optimization (Denver, Colorado: American Water Works Association, 2005).
40. Rosenfeldt, E.J., K.G. Linden, S. Canonica, and U. Von Gunten, "Comparison of the Efficiency of OH Radical Formation During Ozonation and the Advanced Oxidation Processes O3/H2O2 and UV/ H2O2", Water Res., 40:3695-3704 (2006).
41. Stackelberg, P.E., J. Gibs, E.T. Furlong, M.T. Meyer, S.D. Zaugg, and R.L. Lippincott, "Efficiency of Conventional Drinking-Water-Treatment Processes in Removal of Pharmaceuticals and Other Organic Compounds", Sci. Total Environ., 377:255-272 (2007).
42. Stackelberg, P.E., E.T. Furlong, M.T. Meyer, S.D. Zaugg, A.K. Henderson, and D.B. Reissman, "Persistence of Pharmaceutical Compounds and Other Organic Wastewater Contaminants in a Conventional Drinking Water Treatment Plant", Sci. Total Environ., 329:99-113 (2004).
43. Stumpf, M., T.A. Ternes, R.-D. Wilken, S.V. Rodrigues, and W. Baumann, "Polar Drug Residues in Sewage and Natural Waters in the State of Rio de Janeiro, Brazil", Sci. Total Environ., 225:135-141 (1999).
44. Safe, S.H., "Endocrine Disruption and Human Health-Is There a Problem? An Update", Environ. Health Perspect., 108(6):487-493 (2000).
45. Schottler, S.P., S.J. Eisenreich, N.A. Hines, and G. Warren, "Temporal and Spatial Trends of Atrazine, Desthylatrazine and Desisopropylatrazine in the Great Lakes", ACS Symposium Series, 683:208-226 (1998).
46. Sharpe, R.M. and D.S. Irvine, "How Strong is the Evidence of a Link between Environmental Chemicals and Adverse Effects on Human Reproductive Health?", Brit. Med. J., 328:447-451 (2004).
47. Snyder, S., E. Wert, H. Lei, P. Westerhoff, and Y. Yoon, Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes (Denver, Colorado: AwwaRF, 2007).
48. Snyder, S.A., E.C. Wert, D.J. Rexing, R.E. Zegers, and D.D. Drury, "Ozone Oxidation of Endocrine Disruptors and Pharmaceuticals in Surface Water and Wastewater", Ozone: Sci. Eng., 28(6):445-460 (2006).
49. Snyder, S.A., P. Westerhoff, Y. Yoon, and D.L. Sedlak, "Pharmaceuticals, Personal Care Products, and Endocrine Disruptors in Water: Implications for the Water Industry", Environ. Eng. Sci., 20(5):449-469 (2003).
50. Sumpter, J.P., "Endocrine Disruptors in the Aquatic Environment: An Overview", Acta Hydroch. Hydrob., 33(1):9-16 (2005).
51. Ternes, T.A., "Occurrence of Drugs in German Sewage Treatment Plants and Rivers", Water Res., 32(11):3245-3260 (1998).
52. Ternes, T.A., M. Meisenheimer, D. Mcdowell, F. Sacher, H.-J. Brauch, G. Preuss, U. Wilme, and N. Zulei-Seibert, "Removal of Pharmaceuticals During Drinking Water Treatment", Environ. Sci. Technol., 36:3855-3863 (2002).
53. Urfer, D. and P. Huck, "Effects of Hydrogen Peroxide Residuals on Biologically Active Filters", Ozone Sci. Eng., 19:371-386 (1997).
54. Vanderford, B.J. and S.A. Snyder, "Analysis of Pharmaceuticals in Water by Isotope Dilution Liquid Chromatography/Tandem Mass Spectrometry", Environ. Sci. Technol., 40:7312-7320 (2006).
55. Vieno, N.M., H. Harkki, T. Tuhkanen, and L. Kronberg, "Occurrence of Pharmaceuticals in River Water and Their Elimination in a Pilotscale Drinking Water Treatment Plant", Environ. Sci. Technol., 41:5077-5084 (2007).
56. Vieno, N., T. Tuhkanen, and L. Kronberg, "Removal of Pharmaceuticals in Drinking Water Treatment: Effect of Chemical Coagulation", Environ. Technol., 27:183-192 (2006).
57. Von Gunten, U., "Ozonation of Drinking Water: Part I. Oxidation Kinetics and Product formation", Water Res., 37:1443-1467 (2003).
58. Webb, S., T. Ternes, M. Gilbert, and K. Olejniczak, "Indirect Human Exposure to Pharmaceuticals via Drinking Water", Toxicol. Lett., 142(3):157-167 (2003).
59. Wert, E.C., F.L. Rosario-Oritz, D.D. Drury, and S. Snyder, "Formation of Oxidation Byproducts from Ozonation of Wastewater", Water Res., 41:1481-1490 (2007).
60. Westerhoff, P., "Removal of Endocrine Disruptors, Pharmaceuticals and Personal Care Products During Water Treatment", Southwest Hydrol., 2(6):18-19 (2003).
61. Westerhoff, P., Y. Yoon, S. Snyder, and E. Wert, "Fate of Endocrine Disruptor, Pharmaceutical and Personal Care Product Chemicals During Simulated Drinking Water Treatment Process", Environ. Sci. Technol., 39(17):6649-6663 (2005).
62. Zweiner, C. and F.H. Frimmel, "Oxidative Treatment of Pharmaceuticals in Water", Water Res., 34(6):1881-1885 (2000). ttp://www.srcinc.com/ what-we-do/databaseforms.aspx?id=385 visited: 2200 hrs 21 February, 2009.